FHC-silencing of a human metastatic melanoma cell line results in a substantial modification of gene expression that is accompanied, in vitro, by decreased growth activity and reduced invasiveness and cell adhesion capabilities, and, in vivo, by a 4-fold reduction of the tumor growth capacity [20]. This evidence concerns the gene FTH1 and melanoma.